Discovery of new pyrimidine-5-carbonitrile derivatives as anticancer agents targeting EGFRWT and EGFRT790M

Author:

Nasser Ahmed A.12345,Eissa Ibrahim H.12345ORCID,Oun Mohamed R.12345,El-Zahabi Mohamed A.12345,Taghour Mohammed S.12345,Belal Amany67895ORCID,Saleh Abdulrahman M.12345,Mehany Ahmed B. M.1011345,Luesch Hendrik1213141516ORCID,Mostafa Ahmad E.1723185,Afifi Wael M.1723185,Rocca James R.1213141519,Mahdy Hazem A.12345

Affiliation:

1. Pharmaceutical Medicinal Chemistry & Drug Design Department

2. Faculty of Pharmacy (Boys)

3. Al-Azhar University

4. Cairo 11884

5. Egypt

6. Medicinal Chemistry Department

7. Faculty of Pharmacy

8. Beni-Suef University

9. Beni-Suef 62514

10. Zoology Department

11. Faculty of Science

12. Department of Medicinal Chemistry

13. University of Florida

14. Gainesville

15. USA

16. Center for Natural Products

17. Pharmacognosy and Medicinal Plants Dept.

18. Cairo

19. AMRIS Facility

Abstract

A new series of pyrimidine-5-carbonitrile derivatives has been designed as ATP mimicking tyrosine kinase inhibitors of the epidermal growth factor receptor (EGFR).

Publisher

Royal Society of Chemistry (RSC)

Subject

Organic Chemistry,Physical and Theoretical Chemistry,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3